Black Diamond Therapeutics (BDTX)

• Market cap: $215M
• 1 day: -1.31%
• 5 days: -1.31%
• 1 month: -4.56%
• 3 months: 34.64%
• 6 months: 59.07%
• Year to date: 76.17%
• 1 year: 45.56%
• 5 years: -88.3%
• 10 years: -90.45%
• Sector: Healthcare
• Industry: Biotechnology

About: Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

Employees: 54